Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$6.3 - $8.46 $176,494 - $237,006
-28,015 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.56 - $7.13 $118,145 - $184,731
-25,909 Reduced 48.05%
28,015 $163,000
Q2 2019

Aug 13, 2019

BUY
$5.39 - $6.26 $6,349 - $7,374
1,178 Added 2.23%
53,924 $298,000
Q1 2019

May 14, 2019

BUY
$5.12 - $6.18 $270,059 - $325,970
52,746 New
52,746 $302,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $271M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.